Sodium levels in Canadian restaurant menu items compared to UK National Salt Reduction Initiative (NSRI) targets by UK NSRI food category. حسب Caroline G. Middleton (22041479)

الموضوعات:

Changes in sodium levels, serving sizes, and calories in matched restaurant menu items (2016–2020) by sodium reduction or increase. حسب Caroline G. Middleton (22041479)

الموضوعات:

Sodium level changes in matched restaurant menu items (2016–2020) by UK NSRI food category. حسب Caroline G. Middleton (22041479)

الموضوعات:

Sodium levels (mg/100 g) in matched restaurant menu items in 2016 and 2020 by UK NSRI food categories with ≥ 10 items. حسب Caroline G. Middleton (22041479)

الموضوعات:

Effect of SS-31 on mice lung tissue inflammation induced by BLM. حسب Quankuan Gu (20539301)

الموضوعات:

Effect of SS-31 on bleomycin-induced body weight loss in mice. حسب Quankuan Gu (20539301)

الموضوعات:

Effect of SS-31 on mice lung tissue inflammation induced by BLM. حسب Quankuan Gu (20539301)

الموضوعات:

Primers used for RT-PCR. حسب Quankuan Gu (20539301)

الموضوعات:

Pathological staining and the pathological score. حسب Quankuan Gu (20539301)

الموضوعات:

Mitochondrial structural changes and oxidative stress. حسب Quankuan Gu (20539301)

الموضوعات:

Effect of SS-31 on mouse body weight and inflammatory factors in serum. حسب Quankuan Gu (20539301)

الموضوعات:

Effect of SS-31 on apoptosis in lung tissues. حسب Quankuan Gu (20539301)

الموضوعات:

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. حسب Tosi M. Mwakyandile (16408705)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات: